| |
PRODUCT
EVALUATION CHECKLIST
pdf Michael
Scriven April
2000 |
| This product
evaluation checklist was designed, used, and multiply revised in a very
specific context. It was used to evaluate educational products--developed
with federal funding--that were submitted with appropriate documentation
about effectiveness to a review panel that made recommendations for the
distribution of federal dissemination funds. Instructions
to raters: Circle one number under Rate. Check (or
double check) one (or more) line(s) under Consider. Use
an "X" to indicate deficiencies instead of strengths.
Consider:
___ Number affected
___ Social/educational
significance
___ Absence of substitute
___ Multiplicative effects
___ Other |
Rate:
4 Maximum priority,
a desperate need
3 Great importance
2 Probability of
significant need
1 Possibly significant
need
0 No good evidence of
significant need |
Comments: |
Consider:
___ Dissemination plan:
clarity, feasibility,
ingenuity, economy
___ Size
___ Importance
___ Other |
Rate:
4 Very large and/or
very important market will be reached
3 Large and/or
important market will be reached
2 Significant market
will probably be reached
1 Possible, but
not probable, that a significant market will be reached
0 Inadequate evidence
to suggest that a significant market will be reached |
Comments: |
Consider:
___ Final version?
___ Typical user?
___ Typical level of
support?
___ Typical setting?
___ Typical time frame?
___ Other |
Rate:
4 Perfectly typical
3 Minor differences
2 Reasonable bet
for generalization
1 Serious weakness
0 Relevance unclear |
Comments: |
|
4. WERE THE EFFECTS
MEASURED ON TRUE CONSUMERS? |
Consider:
___ Congress?
___ Federal agency?
___ State department?
___ District?
___ Principal?
___ Teacher?
___ Student?
___ Taxpayer?
___ Other |
Rate:
4 Full data on
all relevant consumers
3 Fair data on
all relevant consumers
2 Good data on
the most important consumers
1 Weak data on
the most important consumers
0 Only speculation
about the most important consumers |
Comments: |
|
5. WAS SERIOUS
COST ANALYSIS DONE? |
Consider:
___ Indirect costs included
___ Opportunity costs
included
___ Nonmoney costs included
___ Start-up costs included |
Rate:
4 Very thorough
analysis
3 Good approximation
2 Rough estimate
1 Poor estimate
0 Potentially
fatal omissions |
Comments: |
|
6. WERE LONG-TERM
EFFECTS CHECKED? |
Consider:
___ Week to month later
___ Month to year later
___ Year to few years
later
___ Many years later
___ On-the-job or life-space
sample |
Rate:
4 Good direct
evidence about the effects at times needed
3 Some direct
evidence about the effects at times needed
2 Follow-up
gives reasonable support to a conclusion about the effects when
needed
1 Follow-up
or other data suggest a conclusion about the effects when needed
0 Useless
or no follow-up; no other grounds for inferring long-term |
Comments: |
|
7. WERE SIDE
EFFECTS DILIGENTLY SOUGHT? |
Consider:
___ Comprehensive search?
___ Skilled?
___ Independent?
___ Goal-free?
___ During/end/later? |
Rate:
4 Meets all
requirements well
3 Generally
good
2 Barely
acceptable
1 Some study
made, but incomplete
0 No worthwhile
study |
Comments: |
|
8. WAS THE
PROCESS SYSTEMATICALLY EVALUATED? |
Consider:
___ Implementation index?
___ Ethics?
___ Professional standards?
___ Judge-observer reliability?
___ Affective dimension?
___ Content validity? |
Rate:
4 Passes
with flying colors
3 Appears
satisfactory
2 Reasonable
risk
1 Serious
omission(s)
0 Highly
inadequate |
Comments: |
|
9. WAS CAUSATION
ESTABLISHED? |
Consider:
___ Randomized- experimental
design?
___ Quasi-experimental
design?
___ Ex post facto?
___ MO method?
___ A priori interpretation
of correlational data? |
Rate:
4 Impeccable
3 Good bet
2 Plausible
bet
1 Weak bet
0 Hopeless
bet |
Comments: |
|
10. WERE CRITICAL
COMPARISONS MADE? |
Consider:
___ No treatment group
___ Existing competitors
___ Projected competitors
___ Created competitors
___ Hypothesized competitors |
Rate:
4 Good data
on all important competitors
3 Good data
on the most important competitors
2 Fair data
on the most important competitors
1 Lacking
data on some of the more important competitors
0 Little
or no useful comparative data |
Comments: |
|
11. OVERALL--STATISTICAL
SIGNIFICANCE* |
Consider:
___ Appropriate analysis?
___ Appropriate significance
level? |
Rate:
4 Flawless
analysis, astronomical significance
3 High significance,
well-tested
2 Reasonably
significant
1 Marginal
significance
0 Not shown
to be significant |
Comments: |
|
12. OVERALL--EDUCATIONAL
SIGNIFICANCE* |
Consider:
___ Independent
judgment?
___ Expert judgment?
___ Judgment based on
item analysis?
___ Judgment based on
raw scores?
___ Cultural concerns
addressed?
___ Teaching to the tests?
___ Testing to the teaching?
___ Congruence with needs?
___ Side effects taken
into account?
___ Ethical concerns
addressed? |
Rate:
4 Very high
importance demonstrated
3 High importance
demonstrated
2 Moderate
importance demonstrated
1 Slight
or rather uncertain importance
0 Negligible
or unknown importance |
Comments: |
| *
It will be especially helpful here to use either checks or 0-4 scores
or A-F grades alongside these factors to indicate the basis for
the overall rating. |
| This checklist
is being provided as a free service to the user. The provider of
the checklist has not modified or adapted the checklist to fit the
specific needs of the user and the user is executing his or her
own discretion and judgment in using the checklist. The provider
of the checklist makes no representations or warranties that this
checklist is fit for the particular purpose contemplated by user
and specifically disclaims any such warranties or representations.
|
|